This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our
Privacy Policy.
Accept
Gain insight into
research trends
and
influential papers
with
Research Intelligence.
Search everything
Product tour
About us
Our data
Use cases
Pricing
Sign in
Sign up
Home
Research Intelligence
Pro
Expert Finder
Pro
Scinapse Trends
Paper Search
Journal Search
Collections
Favorites
History
Notes
Keyword Alerts
Submit Feedback
Settings
doi.org/10.1007/s40265-017-0817-y
Other
Glecaprevir/Pibrentasvir: First Global Approval
Yvette N. Lamb
27
View all 1 authors
Drugs
13.00
Volume: 77, Issue: 16, Pages: 1797 - 1804
Published
: Sep 19, 2017
71
Citations
Sources
Cite
Save
Basic Info
Analytics
References
Citations
Abstract
No abstract.
Paper Fields
Virus
NS5A
Regimen
Cirrhosis
Antiretroviral therapy
Internal medicine
Viral load
Medicine
Hepacivirus
Gastroenterology
Hepatitis C virus
Protease inhibitor (pharmacology)
Virology
Paper Details
Title
Glecaprevir/Pibrentasvir: First Global Approval
DOI
doi.org/10.1007/s40265-017-0817-y
Published Date
Sep 19, 2017
Journal
Drugs
Volume
77
Issue
16
Pages
1797 - 1804
Notes
To use the Note feature, you need to be logged in. Please
sign in.
History
View all history
Jarque–Bera Test and its Competitors for Testing Normality – A Power Comparison
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.
Skip
Next